HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 886536Generated: October 30, 2026
2-Chlorophenylhydrazine hydrochloride → 9-bromo-2-(1-(2-chlorophenyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine
https://huagongshe.com/reaction/886536
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2-Chlorophenylhydrazine hydrochloride | HCID 443287 | — |
| Reactant | 9-bromo-N-formyl-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2-carboxamide | HCID 58204570 | — |
| Solvent | Acetic Acid | HCID 176 | — |
| Product | 9-bromo-2-(1-(2-chlorophenyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine | HCID 58204901 | 65.2% |
Reaction Steps
To a solution of 9-bromo-N-formyl-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2-carboxamide (350 mg, 1.04 mmol) in HOAc (10 ml) was added (2-chlorophenyl)hydrazine hydrochloride (557 mg, 3.13 mmol) in one portion. The resulting mixture was stirred at 80° C. for 4 h. The reaction mixture was cooled to room temperature and concentrated. The residue was dissolved in MeOH and purified by chromatography on silica gel (Hexanes: EtOAc=10:1-1:1) to give 9-bromo-2-(1-(2-chlorophenyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine (300 mg, 65%). LCMS (ESI): m/z 443.7 (M+H+)
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08242104B2 |
|---|
| Source dataset | uspto-grants-2012_08 |
|---|
| ORD ID | ord-fe4bf180db624b46ac9fb81d7709d179 |
|---|
| Source note | uspto-grants-2012_08 |
|---|